Log In
Print
BCIQ
Print
Print this Print this
 

mocetinostat (MGCD0103)

Also known as: formerly MG-0103

  Manage Alerts
Collapse Summary General Information
Company Mirati Therapeutics Inc.
DescriptionIsoform-selective small molecule histone deacetylase (HDAC) inhibitor
Molecular Target Histone deacetylase 1 (HDAC1) ; Histone deacetylase 2 (HDAC2)
Mechanism of Action 
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today